Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | SMYD3 | Q9H7B4 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | TNKS | O95271 | 1/20 | 0.39 |
| ▸ | PARP1 | P09874 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27123175 | 0.94 | HTR1A (0.39) | LIPGHTR1ATSHRTNKSPARP1 | |
| SCHEMBL30015013 | 0.89 | TSHR (0.43) | LIPGTSHRNPSR1 | |
| SCHEMBL27123389 | 0.89 | FFAR4 (0.38) | HTR1ASMYD3TNKSPARP1 | |
| SCHEMBL30014467 | 0.89 | FFAR4 (0.38) | HTR1ASMYD3TNKSPARP1 | |
| SCHEMBL28868792 | 0.88 | HSD11B1 (0.40) | LIPGTSHRNPSR1 | |
| SCHEMBL30267059 | 0.87 | SOS1 (0.42) | TNKSPARP1 | |
| SCHEMBL29277059 | 0.86 | HSD11B1 (0.39) | HTR1ATSHRNPSR1 | |
| SCHEMBL29201772 | 0.86 | HSD11B1 (0.39) | TSHR | |
| SCHEMBL25920280 | 0.85 | PRKAG1 (0.40) | LIPGHTR1ASMYD3TSHRNPSR1 | |
| SCHEMBL30014221 | 0.85 | ITGB3 (0.38) | HTR1ATSHRNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4613748-A1 | IRAK4 DEGRADATION AGENT AND USE THEREOF | Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. (CN) | 2025-09-10 | — | — | EP | disclosed |
| WO-2023025159-A1 | IRAK4 DEGRADATION AGENT, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 上海领泰生物医药科技有限公司 | 2023-03-02 | — | — | WO | disclosed |